Investigation of Pain Coping Methods and Related Factors in Postmenopausal Women
Descripción general del estudio
Estado
Condiciones
Descripción detallada
Musculoskeletal pain (MSP) reflects of musculoskeletal conditions related to tissues such as tendons, muscles, ligaments, nerves, and other joint structures. If MSP lasts for longer than three months, it becomes chronic. The prevalence of chronic MSP (cMSP) increases with aging and its ratio changes between 35,7% and 49,8%. The previous studies demonstrated the differences in the prevalence of cMSP between men and women. According to most of the studies, older women adults are more vulnerable to experience than men due to some differences in perception of pain such as biological characteristics, their roles in daily life, beliefs or coping strategies with pain.
Oestrogen has a prominent role in the physiology of muscles, tendons, ligaments, and bones. The decline of this sex hormone during menopause transition could lead to MSP, particularly in the postmenopausal period. Indeed, an increasing rate of cMSP in postmenopausal women has been reported.
Coping strategies with pain are used to manage the pain and its impacts. Coping with pain requires the self-regulation of individuals using cognitive and behavioral reactions. Dealing with cMSP is a process that can need the making of changes in daily life and activities This study aimed to compare active and passive coping strategies being used and pain severity in postmenopausal women according to their age, marital status, educational status, and exercise habits. Also, subdomains of strategies and subdomains of pain and the relationship between pain and coping strategies in postmenopausal women with cMSP will be examined.
Tipo de estudio
Inscripción (Actual)
Contactos y Ubicaciones
Ubicaciones de estudio
-
-
-
Mersin, Pavo
- European University of Lefke
-
-
Criterios de participación
Criterio de elegibilidad
Edades elegibles para estudiar
Acepta Voluntarios Saludables
Géneros elegibles para el estudio
Método de muestreo
Población de estudio
Descripción
Inclusion Criteria:
- complaints of pain in anywhere of their body.
- presenting at least 1 year of amenorrhea
- being between the ages of 50-69 years.
Exclusion Criteria:
- have rheumatological, orthopedic and neurological diseases,
- have compression fractures, malignancies,
- have a chronic disease that will lead to secondary osteoporosis,
- have a drug use that will lead to secondary osteoporosis
Plan de estudios
¿Cómo está diseñado el estudio?
Detalles de diseño
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
|---|---|---|
|
McGill Pain Questionnaire
Periodo de tiempo: 15 minutes
|
This tool is used for assesment of pain, namely; body part of pain, timeframe, characteristic and severity of pain.
As score increases, pain condition worsens.
|
15 minutes
|
|
Pain Coping Inventory (PCI)
Periodo de tiempo: 10 minutes
|
This tool is used for assessment of pain coping strategies.
The higher score received means that coping strategy is used more.
|
10 minutes
|
|
Timed up and go test
Periodo de tiempo: 5 minutes
|
This tool is used for assessment of functional mobility.
The duration to complete the task (in seconds) is used as a score.
As the score increase, the functional mobility decrease.
|
5 minutes
|
Colaboradores e Investigadores
Patrocinador
Investigadores
- Investigador principal: Beliz B Kaygısız, PT, PhD, European University of Lefke
- Director de estudio: Nuray ELİBOL, Ege university
- Silla de estudio: Sevim Acaröz Candan, T.C. ORDU ÜNİVERSİTESİ
Fechas de registro del estudio
Fechas importantes del estudio
Inicio del estudio (Actual)
Finalización primaria (Actual)
Finalización del estudio (Actual)
Fechas de registro del estudio
Enviado por primera vez
Primero enviado que cumplió con los criterios de control de calidad
Publicado por primera vez (Actual)
Actualizaciones de registros de estudio
Última actualización publicada (Actual)
Última actualización enviada que cumplió con los criterios de control de calidad
Última verificación
Más información
Términos relacionados con este estudio
Palabras clave
Otros números de identificación del estudio
- ÜEK/47/01/12/1920/05
Plan de datos de participantes individuales (IPD)
¿Planea compartir datos de participantes individuales (IPD)?
Información sobre medicamentos y dispositivos, documentos del estudio
Estudia un producto farmacéutico regulado por la FDA de EE. UU.
Estudia un producto de dispositivo regulado por la FDA de EE. UU.
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .